Ariad Pharmaceuticals Deemed a Recommended Buy and 4 Stock Analyses to Know Now
Amgen Inc. (NASDAQ:AMGN): Current price $82.54
Amgen Inc. was mentioned positively at UBS.
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN): Current price $94.04
Alexion Pharmaceuticals, Inc.’s shares were defended at Brean Capital.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.
Colgate-Palmolive Co. (NYSE:CL): Current price $110.03
Colgate-Palmolive Co. was added to the Focus List at Credit Suisse.
Gulfport Energy Corp. (NASDAQ:GPOR): Current price $41.48
Citing more confidence in their assumptions for Utica after meeting with management, Jefferies raised their price target for Gulfport Energy Corp. The firm said that the company’s Utica results, to date, point to strong productivity and they keep a Buy rating on the stock.
Ariad Pharmaceuticals Inc. (NASDAQ:ARIA): Current price $19.39
RBC Capital recommends buying Ariad Pharmaceuticals Inc.’s stock at current levels, as the firm believes that the launch of the company’s Iclusig drug will meet or beat consensus during its initial stages. The firm believes that upcoming data for the company’s ‘113 drug will provide a positive catalyst to the stock and they maintain an Outperform rating.
Investing Insights: Is Intuitive Surgical Likely to Outperform in 2013?